Register for email alerts and news feeds:
This journal | BMJ Group
rss
Postgraduate Medical Journal 2008;84:46-49; doi:10.1136/pgmj.2007.062711
© 2008 BMJ Publishing Group Ltd and The Fellowship of Postgraduate Medicine.

ORIGINAL ARTICLES

High-power (80 W) potassium titanyl phosphate laser prostatectomy in 128 high-risk patients

J Yuan, H Wang, G Wu, H Liu, Y Zhang, L Yang

Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi’an, PR China

Correspondence to:
DrDr G Wu or J Yuan, Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi’an, China, 710032; wuguojun{at}fmmu.edu.cn or jianliny{at}fmmu.edu.cn

Objective: To evaluate the safety and merits of 80 W potassium titanyl phosphate (KTP) laser prostatectomy in men with high cardiovascular or pulmonary risk, receiving oral anticoagulant medication, or with bleeding disorders.

Methods: A prospective clinical trial was performed in 128 high-risk men with benign prostatic hyperplasia who underwent photoselective vaporisation of the prostate (PVP). The operation time, postoperative serum sodium and packed cell volume were recorded. The International Prostate Symptom Score (IPSS), maximal flow rate (Qmax) and post-void residual urine volume (PVR) were measured at every follow-up visit.

Results: In all patients, KTP laser prostatectomy was performed successfully. The mean (SD) operation time was 51.6 (22.8) min. No blood transfusions were required. No major complications occurred during surgery, and there was no mortality. The mean (SD) catheterisation time was 2.8 (1.6) days. IPSS decreased from 19.2 (6.1) before surgery to 11.5 (8.2), 7.8 (6.4), 6.7 (5.3) and 6.1 (4.6), respectively, at 1, 3, 6 and 12 months after. Qmax increased from 7.0 (2.8) ml/s to 14.5 (9.3), 20.2 (11.5), 21.3 (8.6) and 24.8 (8.0) ml/s, respectively. PVR decreased from 168 (89) ml to 35 (29), 30 (26), 27 (21) and 23 (34) ml, respectively.

Conclusions: 80 W KTP laser prostatectomy is a virtually bloodless, safe and effective procedure for men with high cardiovascular or pulmonary risk or bleeding disorders or taking oral anticoagulant medication.

Keywords: anticoagulants; benign prostatic hyperplasia; laser surgery; prostatectomy


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.